Article metrics

Download PDFPDF
A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix: An NRG Oncology/Gynecologic Oncology Group Study

 

Online download statistics by month:

Online download statistics by month: January 2019 to March 2020

AbstractFullPdf
Jan 2019800
Feb 20193400
Mar 20195800
Apr 20192500
May 20192500
Jun 20191200
Jul 20193906
Aug 20191600
Sep 20193800
Oct 20192200
Nov 20192101
Dec 20192101
Jan 20203801
Feb 20202700
Mar 20201900
Total40309